CSIMarket Company Name, Ticker, Customers, else..


Hst Global Inc   (HSTC)
Other Ticker:  
 


 

Hst Global Inc

HSTC's Financial Statements and Analysis



Hst Global Inc increased third quarter of 2023 net loss per share of $-0.01 compare to net loss per share of $-0.01 recorded in the same quarter a year ago a decrease compare to $-0.01 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ -0.01 $  0 Mill
Unch.     Unch.    



Hst Global Inc 's Revenue fell by 0 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and declined by sequentially.


Hst Global Inc is

More on HSTC's Income Statement



Hst Global Inc 's in thethird quarter of 2023 recorded net loss of $-0.036 million, an increase from net loss of $-0.036 million in III. Quarter a year ago.

Sequentially net loss advanced

More on HSTC's Growth

Hst Global Inc Inventories
In Sep 30 2023 company's net cash and cash equivalents decreased by $0 million


Hst Global Inc does not pay out common stock dividend.

In trailing twelve-month period Hst Global Inc payed $ 0.00 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -0.11 per share from $ -0.10.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2023.


• More on HSTC's Dividends

 Market Capitalization (Millions) 3
 Shares Outstanding (Millions) 5
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Hst Global Inc does not pay out common stock dividend.

In trailing twelve-month period Hst Global Inc had negative $ 0.00 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -0.11 per share from $ -0.10.

Company repurchased 0.00 million shares or 0.00 % in Sep 30 2023.


• More on HSTC's Balance Sheets

 Market Capitalization (Millions) 3
 Shares Outstanding (Millions) 5
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Hst Global Inc Earnings

HST Global Inc Faces Operating Shortfall in Q3 2023, Prioritizes Innovative Strategies for Progress



As the Major Pharmaceutical Preparations industry researchers assess the third quarter performance of 2023, HST Global Inc (HSTC) faces an operating shortfall of $-0.034368 million. Although the company has yet to report any revenue for this period, its recent conduct shows a decline in productivity compared to the same period in 2022. However, HST Global Inc remains committed to developing a lucrative business strategy despite the challenges. This article takes a closer look at HST Global Inc's market and stock performance, highlighting recent changes.
Operating Shortfall in Q3 2023
The third quarter of 2023 has presented some setbacks for HST Global Inc, as they reported an operating shor...

HST Global Inc's Q2 2023 Report Highlights Growing Concerns with Financial Health and Future Prospects



The Major Pharmaceutical Preparations industry has recently witnessed the release of Hst Global Inc's second-quarter performance report for 2023. Unfortunately, the results have left industry consultants concerned about the company's financial health and future prospects. With a significant operating loss and a lack of specified top-line numbers, Hst Global Inc's performance in the April-to-June 2023 quarter has failed to inspire confidence. Additionally, despite a slight improvement in cost-effectiveness from the previous year, the company continues to struggle, shedding light on its ongoing challenges in gaining traction within the highly competitive pharmaceutical market. This bearish article de...

HST Global Inc Faces Operating Shortfall in Q1 2023: Pharma Industry on High Alert

The pharmaceutical industry is constantly evolving, and analysts are closely monitoring the results of the first quarter of 2023. According to recent reports, the Major Pharmaceutical Preparations sector has noted an operating shortfall of $-0.038075 million from HSTC, which has not cited any top-line so far for the January to March 31, 2023 reporting season. However, in order to place the latest results into context, it is important to look at the business accomplishments through the first quarter of 2022 where HSTC reported a comparable operating shortfall of $-0.037333 million.
While HSTC has not yet announced its top-line, the concerning shortfall in operating income in the period January to March 31...


Date modified: 2023-11-08T14:42:57+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com